These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9639400)

  • 1. Enhanced sensitivity to tumor necrosis factor-alpha in doxorubicin-resistant tumor cell lines due to down-regulated c-erbB2.
    Sleijfer S; Asschert JG; Timmer-Bosscha H; Mulder NH
    Int J Cancer; 1998 Jul; 77(1):101-6. PubMed ID: 9639400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modulation of human small cell lung cancer cell line GLC4/ADR multidrug resistance in the inhibition of multidrug resistance-associated protein and its antisense].
    Peng X; Feng F; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):355-8. PubMed ID: 11810759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells.
    de Groot DJ; Timmer T; Spierings DC; Le TK; de Jong S; de Vries EG
    Br J Cancer; 2005 Apr; 92(8):1459-66. PubMed ID: 15812552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel.
    Withoff S; Keith WN; Knol AJ; Coutts JC; Hoare SF; Mulder NH; de Vries EG
    Br J Cancer; 1996 Aug; 74(4):502-7. PubMed ID: 8761362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
    Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High cytotoxic sensitivity of the human small cell lung doxorubicin-resistant carcinoma (GLC4/ADR) cell line to prodigiosin through apoptosis activation.
    Llagostera E; Soto-Cerrato V; Joshi R; Montaner B; Gimenez-Bonafé P; Pérez-Tomás R
    Anticancer Drugs; 2005 Apr; 16(4):393-9. PubMed ID: 15746575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
    Withoff S; de Vries EG; Keith WN; Nienhuis EF; van der Graaf WT; Uges DR; Mulder NH
    Br J Cancer; 1996 Dec; 74(12):1869-76. PubMed ID: 8980384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell lines.
    Bakker M; Renes J; Groenhuijzen A; Visser P; Timmer-Bosscha H; Müller M; Groen HJ; Smit EF; de Vries EG
    Int J Cancer; 1997 Nov; 73(3):362-6. PubMed ID: 9359483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines.
    Yamazaki K; Isobe H; Hanada T; Betsuyaku T; Hasegawa A; Hizawa N; Ogura S; Kawakami Y
    Cancer Chemother Pharmacol; 1997; 39(3):192-8. PubMed ID: 8996519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation.
    Boonstra R; Timmer-Bosscha H; van Echten-Arends J; van der Kolk DM; van den Berg A; de Jong B; Tew KD; Poppema S; de Vries EG
    Br J Cancer; 2004 Jun; 90(12):2411-7. PubMed ID: 15150577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
    Harris LN; Yang L; Tang C; Yang D; Lupu R
    Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
    Järvinen TA; Tanner M; Rantanen V; Bärlund M; Borg A; Grénman S; Isola J
    Am J Pathol; 2000 Mar; 156(3):839-47. PubMed ID: 10702400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.
    Andoh T; Nishizawa M; Hida T; Ariyoshi Y; Takahashi T; Ueda R
    Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.
    de Jong S; Zijlstra JG; Mulder NH; de Vries EG
    Cancer Chemother Pharmacol; 1991; 28(6):461-4. PubMed ID: 1657425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
    de Jong S; Zijlstra JG; de Vries EG; Mulder NH
    Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
    Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
    Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line.
    Meijer C; Mulder NH; Timmer-Bosscha H; Zijlstra JG; de Vries EG
    Cancer Res; 1987 Sep; 47(17):4613-7. PubMed ID: 3040227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.